Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 77,814 shares at $17.16 ($1.3M) on 2021-11-29, disclosed to the SEC on 2021-12-01.
Open-market sale of $1.3M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.16 | 22,437 | $385K | 28.9% |
| 2 | $17.16 | 22,437 | $385K | 28.9% |
| 3 | $16.94 | 600 | $10K | 0.8% |
| 4 | $16.98 | 4,000 | $68K | 5.1% |
| 5 | $17.04 | 7,770 | $132K | 9.9% |
| 6 | $17.04 | 7,770 |
| $132K |
| 9.9% |
| 7 | $17.11 | 12,800 | $219K | 16.4% |
| Total | $17.12 avg | 77,814 | $1.3M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |